Hypertension in diabetes study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications

Journal of Hypertension

Volumn 11, Issue 3, 1993, Pages 309-317

[No Author Info available]

Author keywords

ECG; Epidemiology; High density lipoprotein cholesterol; Hypertension; Insulin; Triglyceride; Type 2 diabetes; UK Prospective Diabetes Study; Urate; antihypertensive therapy

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URATE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; URINE LEVEL;

BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETIC ANGIOPATHIES; FEMALE; GREAT BRITAIN; HUMAN; HYPERTENSION; MALE; MIDDLE AGE; OBESITY IN DIABETES; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027286024     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199303000-00012     Document Type: Article

References (58)

1. Garcia MJ, McNamara PM, Gordon T, Kannell WB: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up. Diabetes 1974, 23:105-111.
2. Panzram G, Zabel-Langhenning R: Prognosis of diabetes mel-litus in a geographically defined population. Diabetologia 1981, 20:587–591.
3. United Kingdom Prospective Diabetes Study: III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. Hypertension 1985, 7 (suppl II):II8-II13.
4. Standl E, Stiegler H, Roth R, Schulz K, Lehmacher W: On the impact of hypertension on the prognosis of NIDDM: results of the Schwabing GP-Program. Diabete Metab 1989, 15:352–358.
5. Pell S, D'Alonzo A: Some aspects of hypertension in diabetes mellitus. JAMA 1967, 202:104–110.
6. Pell S, D'Alonzo A: Factors associated with long-term survival of diabetics. JAMA 1970, 214:1833–1840.
7. Goodkin G: Mortality factors in diabetes: a 20 year mortality study. J Occup Med 1975, 17:716–721.
8. Fuller JH: Coronary heart disease risk and impaired glucose tolerance: the Whitehall Study. Lancet 1980, 1:1373–1376.
9. Rosengren A, Weiun L, Tsipogianni A, Wilhelmsen L: Impact of cardiovascular risk factors on coronary heart disease among middle aged diabetic men: a general population study. BMJ 1989, 299:1127–1131.
10. The World Health Organization Multinational Study of Vascular Disease in Diabetics: Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. Diabetologia 1985, 28:615–640.
11. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al: Blood pressure, stroke and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765–774.
12. Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, et al.: Overall and coronary heart disease mortality rates in relation to major risk factors in 325, 348 men screened for the MRFIT. Am Heart J 1986, 112:825–836.
13. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al: Blood pressure, stroke, and coronary heart disease: part 2, short term reductions in blood pressure: overview of randomised drug trials in their epidemi-ological context. Lancet 1990, 335:827–838.
14. Reaven GM: Insulin resistance, hyperinsulinemia, and hyper-triglyceridemia in the etiology and clinical course of hypertension. Am J Med 1991, 90 (suppl 2A):7S–12S.
15. MacMahon SW, MacDonald GJ, Bucket RB: Plasma lipopro-tein levels in treated and untreated hypertensive men and women. Arteriosclerosis 1985, 5:391–396.
16. Teuscher A, Schnell H, Wilson PWF: Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care 1988, 11:246–251.
17. Hasslacher C, Ritz E, Terpstra J, Gallasch G, Kunowski G, Rall C: Natural history of nephropathy in type 1 diabetes: relationship to metabolic control and blood pressure. Hypertension 1985, 7 (suppl II):1174–1178.
18. Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT: The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int 1982, 21:730–738.
19. Parving HH, Andersen AR, Smidt UH, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 1987, 294:1443–1447.
20. Mogensen CE: The effect of blood pressure intervention on renal function in insulin-dependent diabetes. Diabete Metab 1989, 15:343–351.
21. Christensen CK, Mogensen CE: Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function. J Diabetic Complications 1987, 1:45–52.
22. Morris NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H: A prospective study of mortality among middle-aged diabetic patients: the London cohort of the WHO multinational Study of Vascular Disease in Diabetes II: associated risk factors. Diabetologia 1990, 33:542–548.
23. Jarrett RJ, Viberti GC, Argyropolous A, Hill RD, Mahmus U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabetic Med 1984, 1:17–19.
24. Mogensen CE: Microalbuminuria predicts clinical protein-uria and early mortality in maturity-onset diabetes. N Engl J Med 1984, 310:356–360.
25. Schmitz A, Vaeth M: Microalbuminuria: a major risk factor for non-insulin-dependent diabetes. A 10 year follow-up study of 503 patients. Diabetic Med 1987, 5:126–134.
26. Mattock MB, Keen H, Viberti GC, el-Gohari MR, Murrells TJ, Scott GS, et al: Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988, 31:82–87.
27. UK Prospective Diabetes Study: VIII. Study design, progress and performance. Diabetologia 1991, 34:877–890.
28. The Hypertension in Diabetes Study Group: Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens 1993, 11:319–325.
29. WHO Study Group: Diabetes Mellitus. Geneva: World Health Organization; 1985 [Tech Rep Ser 727].
30. Davis MD, Hubbard LD, Trautman J, Klein R: Conference on insulin pump therapy in diabetes. Multicentre study effect on microvascular disease. Studies of retinopathy: methodology for assessment and classification with fundus photographs. Diabetes 1985, 34 (suppl 3):42–49.
31. Ferris FL, Kassoff A, Bresnick GH, Bailey I: New visual charts for clinical research. Am J Opthalmol 1982, 94:91–96.
32. Rose GA, Blackburn H, Gillum RF, Prineas RJ: Cardiovascular Survey Methods, 2nd edn. Geneva: World Health Organization; 1982.
33. Wright BM, Dore CF: A random-zero sphygmomanometer. Lancet 1970, i:33–35.
34. Albano JM, Ekins RP, Maritz G, Turner RC: A sensitive precise radio-immunoassay of human insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 1972, 70:487–509.
35. Wahlefeld AW: Triglycerides: determination after enzymatic hydrolysis. In Methods of Enzymatic Analysis. 2nd edn, vol 4. Edited by Bergmeyer M. New York: Verlag Chemie Wein-heim/Academic Press; 1974:1831–1835.
36. Siedel J, Schlumberger H, Klose S, Ziegehorn J, Wahlefeld AW: Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 1981, 19:838–839.
37. Burstein M, Scholnick HR, Morfin R: Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970, 11:583–594.
38. Kearney EM, Mount JN, Watts GF, Slavin BM, Kind PRN: Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser. J Clin Pathol 1987, 40:465–468.
39. Di Giorgio J: Automatic determination of serum and urine creatinine. In Clinical Chemistry. Principles and Techniques. Edited by Henry RJ, Cannon DC, Winkelman JW. Hagerstown, Maryland: Harper and Row; 1974:552–553.
40. Westgard JO, Barry PL, Hunt MR: A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 1981, 27:493–501.
41. SAS Institute: Statistical Analysis System, version 6. Cary, North Carolina: SAS Institute; 1990.
42. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H: Control of blood pressure in Scotland: the rule of halves. BMJ 1990, 300:981–983.
43. Bengttson C, Blohme G, Lapidus L, Lindquist O, Lundgren H, Nystrom E, et al.: Do antihypertensive drugs precipitate diabetes? BMJ 1984, 289:1495–1497.
44. Barrett-Connor E, Criqui MH, Klauber MR, Holdbrook M: Diabetes and hypertension in a community of older adults. Am J Epidemiol 1981, 113:276–284.
45. Jarrett RJ, Keen H, McCartney M, Fuller JH, Hamilton PJS, Reid DD, et al: Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension. Int J Epidemiol 1978, 7:15–24.
46. Ostrander LD, Francis T, Hayner NS, Kjelsberg MO, Epstein FH: The relationship of cardiovascular disease to hypergly-caemia. Ann Intern Med 1965, 62:1188–1198.
47. UK Prospective Diabetes Study: IV. Characteristics of newly presenting type 2 diabetic patients: male preponderance and obesity at different ages. Diabetic Med 1988, 5:154–159.
48. Barker DJ, Bull AR, Osmond C, Simmonds SJ: Fetal and pla-cental size and risk of hypertension in adult life. BMJ 1990, 301:259–262.
49. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988, 37:1595–1607.
50. Ferrannini E, Buzzigoli G, Bonnadona R, Giorico MA, Oleggini M, Graziadei L, et al: Insulin resistance in essential hypertension. N Engl J Med 1987, 317:350–357.
51. Landsberg L: Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986, 236:1081–1090.
52. Modan M, Halkin H, Almog S, Lusky A, Eshkil A, Shefi M, et al.: Hyperinsulinaemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985, 75:809–817.
53. Ferrannini E, Natali A: Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 1991, 121:1274–1282.
54. Bjorntorp P: Adipose tissue distribution, plasma insulin, and cardiovascular disease. Diabete Metab 1987, 13:381–385.
55. Hunt SC, Stephenson SH, Hopkins PN, Williams RR: Predictors of an increased risk of future hypertension in Utah: a screening analysis. Hypertension 1991, 17:969–976.
56. Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendroflu-azide and propranolol for the treatment of mild hypertension. Lancet 1981, ii:539–543.
57. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561–1566.
58. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelu WP: Left ventricular mass and incidence of coronary artery disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989, 110:101–107.